S. Matalon (Birmingham, United States Of America), S. Donnelly (Dublin, Ireland)
CD4+CD25+ T lymphocytes in patients with COPD
B. Barcelo, J. Pons, A. Fuster, J. Sauleda, J. Ferrer, A. G. N. Agusti (Palma de Mallorca, Spain)
|  |
Increased intraalveolar level of soluble endothelial protein C receptor in patients with interstitial lung disease
Y. Nishii, E. C. Gabazza, H. Nakahara, H. Fujimoto, H. Yasui, H. Kobayashi, C. N. D‘aressadro, E. Charles, O. Taguchi (Tsu, Japan; Oklahoma, United States Of America)
| |
CD4+ and CD8+ T lymphocytes display a Th2/Tc2 cytokine profile in COPD
B. Barcelo, J. Pons, A. Fuster, J. Sauleda, J. Ferrer, A. G. N. Agustí (Palma de Mallorca, Spain)
| |
Increased sputum IL-1β and IL-5 gene expression in exacerbations of COPD demonstrated with real-time PCR
T. E. McManus, A. M. Marley, S. N. Christie, N. Baxter, H. J. O‘Neill, P. V. Coyle, J. C. Kidney (Belfast, United Kingdom)
| |
Decreased mRNA and protein expression of peroxiredoxin (PRDX6) in the COPD lung
R. J. Davis, M. A. J. Horn, B. Thome-Kromer, R. A. Coleman, K. L. Clark (Royston, United Kingdom)
| |
Vascular remodeling process in usual interstitial pneumonia
E. R. Parra, Y. Rivelle, A. M. Ab‘Saber, V. L. Capelozzi (São Paulo, Brazil)
| |
Vascular activity and vessel density in idiophatic interstitial pineumonias
L. R. S. Da Costa, E. R. Parra, V. L. Capelozzi (São Paulo, Brazil)
| |
Hemostasis disorders and their correction using disaggregates and low-molecular heparins in patients with idiopathic fibrosing alveolitis (IFA)
S. N. Vasilev, G. O. Kaminskaya, B. A. Serebryannaya, I. E. Stepanyan Shmelev, E. I. (Moscow, Russia)
| |
Soluble form of CD95 (Fas/Apo-1) in patients with community-acquired pneumonia
E. V. Makarova, N. V. Menkov, N. I. Egorova, V. V. Novikov (Nizny Novgorod, Russia)
| |
Growth factors in chronic obstructive pulmonary disease
J. Sauleda, A. Noguera, D. Blanquer, A. Fuster, A. R. Pons, J. Pons, A. Agusti (Palma Mallorca, Spain)
| |
Espression of clusterin and CD44 in bronchial biopsies of subjects with asthma and COPD
M. P. Ruggieri, S. Petruzzelli, M. Romagnoli, D. D‘Arca, A. Corti, L. M. Fabbri (Modena, Italy)
| |
Respiratory rehabilitation in the chronical obstructive lung diseases and asthma
S. Djordjevic (Sokobanja, Serbia & Montenegro)
| |
Lack of correlation between apoptotic and anti-angiogenic activity in broncho-alveolar lavages from LPS-instilled volunteers in human lung microvascular endothelial cells
R. Lucas, T. Hristea, M. Pflueger, A. Wendel, J. Hamacher, A. F. Suffredini (Konstanz, Germany; Bethesda, United States Of America)
| |
Oxidative stress as common mechanism exacerbation of chronic respiratory diseases induced by air pollution
A. F. Kolpakova, N. G. Maksimov, V. A. Rogov (Krasnoyarsk, Russia)
| |
Expression of tumour necrosis factor-receptors I and II on BAL and peripheral blood lymphocytes in sarcoidosis patients
P. Krawczyk, R. Kieszko, S. Chocholska, A. Dmoszynska, J. Milanowski (Lublin, Poland)
| |
Activity of pro- and anti- apoptotic factors mRNA expression in eosinophils of asthmatics
I. I. Ivanchuk, A. E. Sazonov, E. S. Ageeva, I. V. Petrova, L. M. Ogorodova (Tomsk, Russia)
| |
NO-generating endothelium function and endothelium-dependent vasodilatation of brachial artery in patients with COPD
E. V. Motkina, V. A. Nevzorova, M. V. Mokshina (Vladivostok, Russia)
| |
Role of neutrophils in airway inflammation in patients with pneumoconiosis and COPD
E. Surkova, G. Orlova, T. Ses (St Petersburg, Russia)
| |
The characteristic of bronchoalveolar lavage fluid is the mirror of inflammatory process in lungs in patients with ankylosing spondyloarthritis
G. N. Shirshikova, M. V. Ilyin, N. I. Korshunov (Yaroslavl, Russia)
| |
Comparison of cytotoxic markers expression on the surface of lymphocytes in BAL fluid and peripheral blood samples from patients with pulmonary sarcoidosis
L. G. Jurgauskiene, E. Danila, R. Malickaite, M. Avizieniene (Vilnius, Lithuania)
| |